How ‘Pac-Man’ cells fail to prevent deadly infection risk in people with cystic fibrosis
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jun-2026 09:15 ET (19-Jun-2026 13:15 GMT/UTC)
Researchers have discovered how part of the body’s immune system could better combat a leading cause of death for people with cystic fibrosis (CF).
A team led by The University of Queensland's Professor Peter Sly and Dr Abdullah Tarique has identified how macrophages – the white blood cells that fight infection in the body – function differently in people with CF, compared to others.
Early-onset intervertebral disc degeneration is partly driven by cellular senescence, yet effective disease-modifying therapies remain limited. Researchers report that the senolytic combination dasatinib and quercetin reduces senescence markers, inflammatory signaling, and degenerative tissue changes in a genetic mouse model of disc disease. In contrast, navitoclax shows no benefit. The study identifies JNK (c-Jun N-terminal kinase) signaling as a key pathway underlying disease progression and therapeutic response, highlighting a potential strategy for slowing spinal disc degeneration.
This study investigates how 6:2 chlorinated polyfluorinated ether sulfonic acid (6:2 Cl-PFESA)—a widely used alternative to perfluorooctane sulfonate (PFOS)—exacerbates antibiotic resistance gene (ARG) proliferation during anaerobic digestion. The research demonstrates that PFESA exposure significantly increases both intracellular and extracellular ARGs, particularly tetracycline and sulfonamide resistance genes, through multiple mechanisms including enhanced mobile genetic element proliferation, extracellular polymeric substance restructuring that immobilizes DNA, oxidative stress-induced membrane damage, and selective enrichment of resistant microbial taxa. These findings reveal that emerging PFAS alternatives pose overlooked ecological and health risks by amplifying antimicrobial resistance spread in wastewater treatment systems, highlighting the need to incorporate resistance indicators into environmental risk assessment frameworks for persistent contaminants.
A new review article highlights the powerful influence of long non-coding RNAs (lncRNAs) in regulating natural killer (NK) cells, revealing promising opportunities to enhance immune responses and improve treatment strategies across multiple diseases.
A newly published review article highlights the emerging importance of the immunoproteasome in the development and progression of diabetes and its wide-ranging complications, offering fresh perspectives on future therapeutic strategies. The findings position this specialized protein complex as a critical regulator of inflammation, metabolism, and cellular health.